Tonix PharmaceuticalsTNXP
那斯達克 · USD
11.76
+0.14
(+1.20%)
收盤 09/17 03:58 (UTC+8)
09/17 03:58 (UTC+8)
Tonix PharmaceuticalsTNXP
11.76
+0.14
(+1.20%)
財務數據
損益表
- 0.02
- 0.02
- 0.03
- 0.03
- 0.02
- 0.02
- 0.03
- 0.05
- 0.07
- 0.14
- -34.32
- -11.04
- 27.81
- -8.50
- -5.93
- -17.74
- 64.66
- 63.83
- 27.61
- 96.92
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 13,544 | 6,878 | 5,390 | 3,290 | 1,998 | 2,429 | 2,582 | 2,822 | 2,208 | 2,482 |
營業成本 | 703 | 1,578 | 1,058 | 1,367 | 3,272 | 943 | 1,183 | 1,555 | 3,367 | 1,660 |
營業毛利 | 12,841 | 5,300 | 4,332 | 1,923 | -1,274 | 1,486 | 1,399 | 1,267 | -1,159 | 822 |
營業費用 | 55,376 | 46,837 | 52,618 | 34,990 | 27,022 | 17,540 | 23,879 | 16,821 | 76,157 | - |
研發費用 | 19,417 | 18,213 | 16,941 | 9,289 | 10,820 | 7,436 | 8,297 | 9,114 | 9,698 | 12,863 |
推銷及管理費用 | 35,959 | 28,624 | 35,677 | 25,701 | 16,202 | 10,104 | 15,582 | 7,707 | 7,502 | 9,310 |
非經常性項目費用 | - | - | - | - | - | - | - | - | 58,957 | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -42,535 | -41,537 | -48,286 | -33,067 | -28,296 | -16,054 | -22,480 | -15,554 | -77,316 | -21,351 |
其他收入及費用 | 1,983 | 1,343 | 1,376 | 1,146 | 24 | -775 | -582 | 1,341 | -1,460 | 6,412 |
利息費用 | - | - | - | 89 | - | - | -954 | - | - | - |
稅前純益 | -40,552 | -40,194 | -46,910 | -32,010 | -28,272 | -16,829 | -22,108 | -14,213 | -78,776 | -14,939 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -40,552 | -40,194 | -46,910 | -32,010 | -28,272 | -16,829 | -22,108 | -14,213 | -78,776 | -14,939 |
基本每股稅後盈餘(元) | -2.44 | -2.93 | -3.98 | -3.59 | -3.86 | -2.84 | -0.10 | -0.23 | -19.21 | -0.17 |
稀釋每股稅後盈餘(元) | -2.39 | -2.93 | -4.15 | -3.59 | -3.96 | -2.84 | 2.89 | 22.67 | -21.97 | -0.17 |
基本平均股數(千股) | 16635.00 | 13707.00 | 11798.00 | 8922.00 | 7327.00 | 5927.00 | 226353.00 | 62666.00 | 4101.00 | 89235.00 |
稀釋平均股數(千股) | 16635.00 | 13707.00 | 11798.00 | 8922.00 | 7327.00 | 5927.00 | 226353.00 | 62666.00 | 4101.00 | 89235.00 |
還原基本每股稅後盈餘(元) | -2.44 | -2.93 | -3.98 | -3.59 | -3.86 | -2.84 | -9.77 | -22.68 | -1920.85 | -535.72 |
還原稀釋每股稅後盈餘(元) | -2.39 | -2.93 | -4.15 | -3.59 | -3.96 | -2.84 | 289.40 | 2267.00 | -2197.28 | -535.72 |
還原基本平均股數(千股) | 16,635 | 13,707 | 11,798 | 8,922 | 7,327 | 5,927 | 2,263 | 626 | 41 | 27 |
還原稀釋平均股數(千股) | 16,635 | 13,707 | 11,798 | 8,922 | 7,327 | 5,927 | 2,263 | 626 | 41 | 27 |
EBITDA(千元) | -39,933 | -39,639 | -46,422 | -31,460 | -27,789 | -16,271 | -22,366 | -13,494 | -77,442 | -13,427 |